NASDAQ:CLDX | Cash Flow Statement | Celldex Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$73.5M
2026-03-31-$78.69M$854,000.00-$65.59M$1.64M$72.12M$327,000.00
2025-12-31-$81.32M$816,000.00-$63.94M$1.28M$55.43M$1.35M
2025-09-30-$67.04M
2025-06-30-$56.6M
2025-03-31-$53.8M$867,000.00-$54.37M$265,000.00$42.95M$202,000.00
2024-12-31-$47.09M$819,000.00-$32.48M$756,000.00$24.05M$386,000.00
2024-09-30-$42.12M
2024-06-30-$35.84M
2024-03-31-$32.81M$775,000.00-$40.64M$344,000.00-$315.21M$436.11M
2023-12-31$759,000.00-$32.53M$666,000.00-$171.16M$217.37M
2023-03-31$726,000.00-$28.57M$585,000.00$52.57M$694,000.00
2022-12-31$673,000.00-$21.76M$235,000.00$31.21M$1.4M
2022-03-31$811,000.00-$24.53M$575,000.00$10.38M$304,000.00
2021-12-31$777,000.00-$14.52M$354,000.00-$18.94M$426,000.00
2021-03-31$775,000.00-$18.08M$567,000.00$43.49M$74,000.00
2020-12-31$755,000.00-$5.21M$247,000.00$30.85M$44,000.00
2020-03-31$1.17M-$12.11M$235,000.00$21.97M$1.64M
2019-12-31$1.15M-$11M$105,000.00$3.22M$2.42M
2019-03-31$1.35M-$13.23M$186,000.00$16.3M$4.16M
2018-12-31$721,000.00-$15.43M$162,000.00$3.35M$3.57M
2018-03-31$1.03M-$28.02M$259,000.00$15.5M$12.06M
2017-12-31$1.02M-$19.52M$190,000.00-$13.38M$18.46M
2017-03-31$1.37M-$35.26M$374,000.00$22.4M$12.9M
2016-12-31$960,000.00-$20.35M$638,000.00$27.78M$3.28M
2016-03-31$742,000.00-$34.9M$540,000.00
2015-12-31$847,000.00-$13.75M$407,000.00
2015-03-31$672,000.00-$32.59M$1.56M
2014-12-31$624,000.00-$22.21M$163,000.00
2014-03-31$579,000.00-$31.88M$195,000.00
2013-12-31$510,000.00-$14.96M$2.32M
2013-03-31$468,000.00-$17.2M$162,000.00
2012-12-31$471,000.00-$13.33M$110,000.00
2012-03-31$544,000.00-$13.55M$42,000.00
2011-12-31$552,000.00-$9.37M$106,000.00
2011-06-30-$10.24M
2011-03-31$562,000.00-$8.86M$202,000.00
2010-12-31$530,000.00-$6.02M$438,000.00
2010-06-30-$9.53M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$258.76M$3.38M-$210.95M$2.71M$209.07M$2.39M
2024-12-31-$157.86M$3.18M-$157.78M$1.92M-$290.13M$441.45M
2023-12-31-$141.43M$3.01M-$107.29M$1.82M-$105.78M$218.46M
2022-12-31$2.9M-$103.73M$1.83M$89.94M$4.08M
2021-12-31$3.07M-$60.91M$1.25M-$216.16M$272.37M
2020-12-31$3.93M-$40.4M$1.55M-$98.22M$171.23M
2019-12-31$4.86M-$46.42M$731,000.00$17.08M$16.26M
2018-12-31$3.58M-$75.24M$813,000.00$29.82M$29.44M
2017-12-31$4.41M-$99.93M$1.79M$46.47M$51.29M
2016-12-31$3.1M-$113.04M$2.75M$68.91M$14.48M
2015-12-31$3M-$98.89M$4.88M-$50.19M$193.15M
2014-12-31$2.39M-$101.54M$1.93M
2013-12-31$1.93M-$67.67M$4.22M
2012-12-31$2.05M-$49.78M$303,000.00
2011-12-31$2.25M-$35.66M$509,000.00
2010-12-31$2.72M-$30.37M$2.1M
2009-12-31$2.58M-$29.87M$528,000.00